Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3858 results

Sort By:

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Study ID: NCT05377320
Start Date: 2026-12
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Clinical Decision Aid

Standard Care

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Study ID: NCT06837220
Start Date: 2026-02-02
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Enhanced Courage to Quit

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches

Study ID: NCT07165808
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

84

Intervention / Treatment

Nicotine pouch: Low dose

Nicotine pouch: High dose

Low pH

High pH

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

Study ID: NCT07200089
Start Date: 2026-01-31
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

NT-I7

Placebo

B-cell Maturation Antigen (BCMA) CART-T therapy

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Sex Differences in Neurobehavioral Response to THC

Study ID: NCT07225777
Start Date: 2026-01-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Dronabinol

Placebo

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

Study ID: NCT06926595
Start Date: 2026-02-01
End Date: 2031-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

Cyclophosphamide (primary intervention for GVHD prophylaxis)

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Study ID: NCT07296120
Start Date: 2026-01-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

Respiratory Syncytial Virus Prefusion F Vaccine (RSVpreF)

Sponsor

The Cooper Health System

Source: clinicaltrials.gov

Share:
Add to list

Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children

Study ID: NCT07284693
Start Date: 2026-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

108

Intervention / Treatment

Phenolic complex k110-42

Neumentix

Sponsor

Mansoura University

Source: clinicaltrials.gov

Share:
Add to list

Laparoscopic Approach in Adhesive Intestinal Obstruction

Study ID: NCT06799208
Start Date: 2026-03
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Laparoscopy

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Artificial Intelligence for Early Detection of Peripheral Artery Disease

Study ID: NCT06505317
Start Date: 2026-07-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

7800

Intervention / Treatment

AI-based PAD screening intervention

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list